Natera

Associate Medical Director

Remote

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, DiagnosticsIndustries

Requirements

Candidates must hold an M.D. or Ph.D. degree, with a minimum of five years of post-fellowship practice experience in GI Oncology, involving the treatment of patients. They should possess knowledge of practice guidelines across various GI cancer types and at least three years of clinical trial experience in academia, the biotech industry, or a comparable setting. Furthermore, a minimum of two years of experience in industry, specifically in Medical Affairs or Clinical Development, with a proven track record of successfully commercializing transplant products (therapeutics or diagnostics) is preferred.

Responsibilities

The Associate Medical Director will collaborate with the Medical Director, Oncology, on the clinical development of molecular diagnostic tools for heart transplant and heart failure, lead the design and implementation of new treatment protocols, recruit industry-leading Principal Investigators and clinical sites for studies, advise on product development, identify clinical needs and opportunities, provide medical interpretation of test results, support physician customers, advise on pre-and post-test counseling for patients, drive medical education efforts, support the publication strategy, provide medical input into regulatory submissions, represent Natera’s medical voice in public relations, maintain HIPAA/PHI privacy compliance, complete relevant training, and maintain current training requirements. They will also be willing to travel over 40% of the time, focusing on transplant-related activities.

Skills

Molecular diagnostics
Clinical development
Protocol design
Clinical trial recruitment
Product development
Test interpretation
Customer support
Medical education
KOL engagement
Publication strategy
Regulatory input
Public relations

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Key Metrics

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI